Retinal Biologics Market - Global Industry Analysis
Retinal Biologics Market By Drug Class (TNF-a Inhibitor and VEGF-A Antagonist), By Indication (Diabetic Retinopathy, Macular Degeneration, Uveitis, Diabetic Macular Edema, and Others), and by Distribution Channel (Retail Sales and Institutional Sales): Global Market Perspective, Comprehensive Analysis, and Forecast, 2018–2025
Published Date: 16-Sep-2019Pharmaceutical
Category: Report Format : PDF
Report Code: ZMR-4744
Status : Published
Global retinal biologics market is expected to generate around USD 28,015 million by 2025, at a CAGR of 11.5% between 2019 and 2025. The worldwide escalation of ophthalmic disorders, due to aging, is the prime factor driving the retinal biologics market globally.